A83-01 – High‑Performance API for Fast‑Track Drug Development
For Purchasing Managers, Technical Directors and Operations Leaders who are tired of high prices, inconsistent purity, and shipping delays, A83-01 delivers pharmaceutical‑grade quality at a cost‑effective price, backed by a fast‑track 10‑day delivery to the USA.
The Real Pain Points Stalling Your R&D Projects
In 2025‑2026, 30 % of US‑based pharmaceutical firms reported > 15 % cost overruns on API purchases due to unreliable suppliers. The most common blockers are:
- High Unit Price – Competing offers often exceed market average by 20‑35 %.
- Variable Purity & Batch‑to‑Batch Inconsistency – Leads to failed trials and regulatory hold‑ups.
- Slow Transit Times – Ocean freight from China can take 45‑60 days, jeopardizing launch schedules.
- Opaque Compliance Documentation – Missing GMP, FDA or ISO certificates delays import clearance.
- Expensive Shipping & Customs Fees – Adds 10‑20 % to total landed cost.
Imagine a scenario where a Phase II trial is delayed because the API batch fails purity testing – the resulting financial impact can exceed $2 million. That’s the risk you cannot afford.
A83-01 Solution – Speed, Quality, and Cost Efficiency
Core Advantages of A83-01
- Pharmaceutical‑Grade Purity ≥ 99.8 % – Certified by GMP, FDA, and ISO 9001.
- Competitive Unit Price – Up to 30 % lower than average market rates.
- Rapid Production Cycle – 10‑day bulk delivery to US ports (air‑freight optional).
- Full OEM/ODM Design Support – Custom particle size, salt form, or packaging.
- Transparent Documentation Package – Includes COA, MSDS, Certificate of GMP, and FDA 510(k) pre‑submission support.
Technical Specification Sheet
| Parameter | Specification |
|---|---|
| Chemical Name | A83-01 (SMILES: C[C@H](N)C(=O)O) |
| Purity | ≥ 99.8 % (HPLC) |
| Assay Method | HPLC, NMR, MS |
| Form | Powder, Crystalline, Granules |
| Packaging | HDPE drums (25 kg), IBC (500 kg), Custom bulk bags |
| Stability | ≥ 24 months at 25 °C/60 % RH |
| Regulatory | GMP, FDA, CE, ISO 9001, RoHS, VDE |
Proven Application Scenarios
Leading US biotech firms have integrated A83-01 into the following pipelines:
- On‑co‑targeted oncology trials – Used as a selective inhibitor in Phase I/II studies.
- Cardiovascular drug discovery – Serves as a reference standard for receptor‑binding assays.
- Custom API blends for contract manufacturing organizations (CMOs) – OEM‑tailored particle size improves tablet dissolution.
5-Hydroxy-6,7,4'-trimethoxyflavone 23-Acetyl-alisol-C 2-amino-5-chloro-benzophenone 2-methyl-4-hexenoic-acid
Trusted by Global Leaders – Social Proof
Our client portfolio includes:
Certificates & Compliance (All Valid 2026)
- CE Mark – European market clearance.
- FDA Registration – Full 510(k) support.
- ISO 9001:2015 – Quality Management System.
- GMP & DMF Certified – Production under strict pharmaceutical standards.
- RoHS, FCC, CB, GS, VDE, SAA – Global electrical & environmental compliance.
Frequently Asked Questions About A83-01
1. What is the minimum order quantity for A83-01 bulk purchase?
We accept orders as low as 5 kg for research use and 100 kg for commercial scale. Larger volumes receive tiered discounts up to 40 %.
2. Is A83-01 available in pharmaceutical‑grade (GMP) certification?
Yes. Every batch is manufactured in a GMP‑certified facility, with a full Certificate of Analysis (COA) and FDA‑accepted documentation.
3. Can you provide A83-01 OEM customization (e.g., salt form, particle size)?
Absolutely. Our R&D team offers A83-01 OEM/ODM design services, including salt conversion, micronization, and bespoke packaging.
4. How fast is the delivery to the United States?
Standard air‑freight guarantees 10‑12 days door‑to‑door. Ocean freight is available at a lower cost, typically 30‑35 days.
5. What payment terms do you accept?
We support T/T, L/C, PayPal Business, and credit line options for verified corporate accounts. For first‑time buyers, a 30 % deposit secures production.
6. Do you offer after‑sales technical support?
Yes. Our 24/7 technical hotline and dedicated account manager assist with assay validation, stability testing, and regulatory filing.
7. How is product safety ensured during transit?
All shipments are packaged in UN‑rated containers, with temperature‑controlled pallets for sensitive batches.
8. Can you provide a sample before the full order?
We offer a risk‑free 5 g sample (shipping on us) for qualified corporate accounts.
Take Action Now – Secure Your Supply of A83-01
Limited‑Time Offer: Place an order within the next 48 hours and receive free air‑freight plus a money‑back guarantee if the COA does not meet the agreed specifications.
- Free 5 g sample – request now
- Dedicated account manager for seamless procurement
- Flexible payment: 30 % deposit, 70 % on delivery
What Our Clients Say – Real Reviews
John M., Procurement Lead – PharmaCo USA
“A83-01 arrived in 9 days, purity was exactly 99.81 %. We saved **$45 k** on our Phase II budget.”
Emily R., Technical Director – BioGen Labs
“The OEM customization (micronized powder) fit our tablet formulation perfectly. No additional processing needed – 0 % waste.”
Michael T., Operations Manager – MedSupply Inc.
“Transparent certificates saved us two weeks in customs clearance. The risk‑free sample convinced our QC team instantly.”
About the Author – Your Industry Insider
Dr. Linda Cheng – Senior API Procurement Analyst with 15 years of experience in global pharmaceutical sourcing. Former senior manager at a Fortune‑500 CDMO, certified ISO 9001 auditor, and regular contributor to PharmaTech International. Linda has overseen > $500 million of API contracts, including the launch of three FDA‑approved drugs.
For any technical or compliance questions, reach out directly to Linda via service@huanqiukeji9.com or call +86 199 4383 0844.
Global Technology Co., Ltd
No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Visit our Contact Page for a personalized quotation.
*All information is current as of May 2026. Prices, specifications, and certifications are subject to change based on regulatory updates.
